CEBPA and acute myeloid leukemia: Specifically, multiomics analyses highlighted an increase in lipid anabolism when C/EBPα and Fms-like tyrosine kinase 3 (FLT3) were coordinately activated in in vivo experiments and in patients with FLT3-mutant acute myeloid leukemia (AML).